20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years von Pan, Hongchao, Gray, Richard, Braybrooke, Jeremy, Davies, Christina, Taylor, Carolyn, McGale, Paul, Peto, Richard, Pritchard, Kathleen I, Bergh, Jonas, Dowsett, Mitch, Hayes, Daniel F

Volltext

Estimating the Risks of Breast Cancer Radiotherapy: Evidence From Modern Radiation Doses to the Lungs and Heart and From Previous Randomized Trials von Taylor, Carolyn, Correa, Candace, Duane, Frances K, Aznar, Marianne C, Anderson, Stewart J, Bergh, Jonas, Dodwell, David, Ewertz, Marianne, Gray, Richard, Jagsi, Reshma, Pierce, Lori, Pritchard, Kathleen I, Swain, Sandra, Wang, Zhe, Wang, Yaochen, Whelan, Tim, Peto, Richard, McGale, Paul

Volltext

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years von Goss, Paul E, Ingle, James N, Pritchard, Kathleen I, Robert, Nicholas J, Muss, Hyman, Gralow, Julie, Gelmon, Karen, Whelan, Tim, Strasser-Weippl, Kathrin, Rubin, Sheldon, Sturtz, Keren, Wolff, Antonio C, Winer, Eric, Hudis, Clifford, Stopeck, Alison, Beck, J. Thaddeus, Kaur, Judith S, Whelan, Kate, Tu, Dongsheng, Parulekar, Wendy R

Volltext

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer von Sparano, Joseph A, Gray, Robert J, Makower, Della F, Pritchard, Kathleen I, Albain, Kathy S, Hayes, Daniel F, Geyer, Charles E, Dees, Elizabeth C, Goetz, Matthew P, Olson, John A, Lively, Tracy, Badve, Sunil S, Saphner, Thomas J, Wagner, Lynne I, Whelan, Timothy J, Ellis, Matthew J, Paik, Soonmyung, Wood, William C, Ravdin, Peter M, Keane, Maccon M, Gomez Moreno, Henry L, Reddy, Pavan S, Goggins, Timothy F, Mayer, Ingrid A, Brufsky, Adam M, Toppmeyer, Deborah L, Kaklamani, Virginia G, Berenberg, Jeffrey L, Abrams, Jeffrey, Sledge, George W

Volltext

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2 von Piccart, M., Hortobagyi, G.N., Campone, M., Pritchard, K.I., Lebrun, F., Ito, Y., Noguchi, S., Perez, A., Rugo, H.S., Deleu, I., Burris, H.A., Provencher, L., Neven, P., Gnant, M., Shtivelband, M., Wu, C., Fan, J., Feng, W., Taran, T., Baselga, J.

Volltext

Endocrine therapy: is the first generation of targeted drugs the last? von Pritchard, K. I.

Volltext

Correlative Analysis of Genetic Alterations and Everolimus Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results F... von Hortobagyi, Gabriel N, Chen, David, Piccart, Martine, Rugo, Hope S, Burris, 3rd, Howard A, Pritchard, Kathleen I, Campone, Mario, Noguchi, Shinzaburo, Perez, Alejandra T, Deleu, Ines, Shtivelband, Mikhail, Masuda, Norikazu, Dakhil, Shaker, Anderson, Ian, Robinson, Douglas M, He, Wei, Garg, Abhishek, McDonald, 3rd, E Robert, Bitter, Hans, Huang, Alan, Taran, Tetiana, Bachelot, Thomas, Lebrun, Fabienne, Lebwohl, David, Baselga, José

Volltext

Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence von DENT, Rebecca, TRUDEAU, Maureen, PRITCHARD, Kathleen I, HANNA, Wedad M, KAHN, Harriet K, SAWKA, Carol A, LICKLEY, Lavina A, RAWLINSON, Ellen, PING SUN, NAROD, Steven A

Volltext

Results of the phase I CCTG IND.231 trial of CX-5461 in patients with advanced solid tumors enriched for DNA-repair deficiencies von Hilton, John, Gelmon, Karen, Bedard, Philippe L., Tu, Dongsheng, Xu, Hong, Tinker, Anna V., Goodwin, Rachel, Laurie, Scott A., Jonker, Derek, Hansen, Aaron R., Veitch, Zachary W., Renouf, Daniel J., Hagerman, Linda, Lui, Hongbo, Chen, Bingshu, Kellar, Deb, Li, Irene, Lee, Sung-Eun, Kono, Takako, Cheng, Brian Y. C., Yap, Damian, Lai, Daniel, Beatty, Sean, Soong, John, Pritchard, Kathleen I., Soria-Bretones, Isabel, Chen, Eric, Feilotter, Harriet, Rushton, Moira, Seymour, Lesley, Aparicio, Samuel, Cescon, David W.

Volltext

Implementing routine collection of EQ-5D-5L in a breast cancer outpatient clinic von Torres, Sofia, Bayoumi, Ahmed M, Abrahao, Ana B K, Trudeau, Maureen, Pritchard, Kathleen I, Li, Chun Nim, Mitsakakis, Nicholas, Liu, Geoffrey, Krahn, Murray

Volltext

Insulin- and Obesity-Related Variables in Early-Stage Breast Cancer: Correlations and Time Course of Prognostic Associations von GOODWIN, Pamela J, ENNIS, Marguerite, PRITCHARD, Kathleen I, TRUDEAU, Maureen E, KOO, Jarley, TAYLOR, Sara K, HOOD, Nicky

Volltext

Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31 von Gelmon, Karen A, Boyle, Frances M, Kaufman, Bella, Huntsman, David G, Manikhas, Alexey, Di Leo, Angelo, Martin, Miguel, Schwartzberg, Lee S, Lemieux, Julie, Aparicio, Samuel, Shepherd, Lois E, Dent, Susan, Ellard, Susan L, Tonkin, Katia, Pritchard, Kathleen I, Whelan, Timothy J, Nomikos, Dora, Nusch, Arnd, Coleman, Robert E, Mukai, Hirofumi, Tjulandin, Sergei, Khasanov, Rustem, Rizel, Shulamith, Connor, Anne P, Santillana, Sergio L, Chapman, Judith-Anne W, Parulekar, Wendy R

Volltext

Randomized Trial of Long-Term Follow-Up for Early-Stage Breast Cancer: A Comparison of Family Physician Versus Specialist Care von GRUNFELD, Eva, LEVINE, Mark N, GINSBURG, David, WOOD, Marjorie, WHELAN, Tim, JULIAN, Jim A, COYLE, Doug, SZECHTMAN, Barbara, MIRSKY, Doug, VERMA, Shailendara, DENT, Susan, SAWKA, Carol, PRITCHARD, Kathleen I

Volltext

Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies von Lee, Philip E., Tierney, Mary C., Wu, Wei, Pritchard, Kathleen I., Rochon, Paula A.

Volltext

Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System von HUDIS, Clifford A, BARLOW, William E, ZUJEWSKI, Jo Anne, COSTANTINO, Joseph P, GRAY, Robert J, PRITCHARD, Kathleen I, CHAPMAN, Judith-Anne W, SPARANO, Joseph A, HUNSBERGER, Sally, ENOS, Rebecca A, GELBER, Richard D

Volltext

Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial von GOSS, Paul E, INGLE, James N, D'SOUZA, David P, CHALCHAL, Haji, SPADAFORA, Silvana, STEARNS, Vered, PEREZ, Edith A, LIEDKE, Pedro E. R, LANG, Istvan, ELLIOTT, Catherine, GELMON, Karen A, CHAPMAN, Judy-Anne W, PRITCHARD, Kathleen I, SHEPHERD, Lois E, ELLIS, Matthew J, SLEDGE, George W, BUDD, G. Thomas, RABAGLIO, Manuela, ANSARI, Rafat H, JOHNSON, David B, TOZER, Richard

Volltext

Randomized Trial of Decongestive Lymphatic Therapy for the Treatment of Lymphedema in Women With Breast Cancer von DAYES, Ian S, WHELAN, Tim J, MANCHUL, Lee, WIERNIKOWSKI, Jennifer, LEVINE, Mark N, JULIAN, Jim A, PARPIA, Sameer, PRITCHARD, Kathleen I, D'SOUZA, David Paul, KLIGMAN, Lyn, REISE, Donna, LEBLANC, Linda, MCNEELY, Margaret L

Volltext

Palbociclib in hormone receptor positive advanced breast cancer: A cost-utility analysis von Raphael, J., Helou, J., Pritchard, K.I., Naimark, D.M.

Volltext

Experimental hookworm infection: a randomized placebo-controlled trial in asthma von Feary, J. R., Venn, A. J., Mortimer, K., Brown, A. P, Hooi, D., Falcone, F. H., Pritchard, D. I., Britton, J. R.

Volltext

HER-2 and Topoisomerase II As Predictors of Response to Chemotherapy von Pritchard, Kathleen I, Messersmith, Hans, Elavathil, Leela, Trudeau, Maureen, O'Malley, Frances, Dhesy-Thind, Bindi

Volltext